Is China Becoming 'Japanificated?' – Asia Manager on Recent Visit |
Equity Research & Insights |
Christopher Johnson |
04/03/24 |
Investors Are Deserting China, so Should I Buy China ETFs? |
ETF Research & Insights |
Valerio Baselli |
30/01/24 |
China Outlook 2024: Policy Support, IPOs, and Optimism |
Special Report |
Kate Lin |
15/12/23 |
Fund Manager Interview: FSSA China's Martin Lau |
Fund Research & Insights |
Kate Lin |
24/11/23 |
China's Emerging Multinationals |
Special Report |
Alison Savas |
07/09/23 |
Country Garden Downgraded by Morningstar |
Equity Research & Insights |
Morningstar |
30/08/23 |
Tick Tock: The Funds Still Exposed to Country Garden |
Fund Research & Insights |
Kate Lin |
29/08/23 |
Country Garden Plunges After Bonds Suspended |
Equity Research & Insights |
Jocelyn Jovene |
14/08/23 |
July's Best and Worst Performing Funds - Ranked! |
Fund Research & Insights |
Sunniva Kolostyak |
08/08/23 |
China's Comeback? Expect an 'N-Shaped' Recovery |
Equity Research & Insights |
Kate Lin |
16/02/23 |
4 Chinese Tech Stocks We Like |
Equity Research & Insights |
Valerio Baselli |
23/01/23 |
Outlook 2023: is China at an Inflection Point? |
Special Report |
Sunniva Kolostyak |
14/12/22 |
How Are Fund Managers Reacting to the China Situation? |
Fund Research & Insights |
Ollie Smith |
30/11/22 |
China Stock Slump Persists After Party Congress |
Equity Research & Insights |
Kate Lin |
27/10/22 |
Emerging Market Stocks: Most Undervalued and Overvalued |
Special Report |
Sunniva Kolostyak |
21/07/22 |
'There Are a Lot of Exciting Growth Areas in China' |
Special Report |
James Gard |
21/07/22 |
China Stocks: The Road to Nowhere |
Economic Insights |
John Rekenthaler |
18/07/22 |
Resilience, Inflation and Security Are Key Future Trends |
Economic Insights |
James Gard |
08/07/22 |
Chinese Stocks: What Went Wrong? |
Equity Research & Insights |
John Rekenthaler |
28/03/22 |
China Stocks: The Road to Nowhere |
Perspectives |
John Rekenthaler |
23/03/22 |
Chinese Wide-Moat Stocks at a Discount |
Equity Research & Insights |
Kate Lin |
14/03/22 |
A User's Guide to China's Stock Market |
Equity Research & Insights |
James Gard |
09/02/22 |
Alibaba Faces Stiff Competition |
Equity Research & Insights |
Kate Lin |
08/02/22 |
Be Choosy With China, it May Pay Off |
Equity Research & Insights |
Ben Johnson |
01/02/22 |
Year of the Tiger: 4 Drivers for Stocks |
Economic Insights |
James Gard |
01/02/22 |
What's Next for Chinese Stocks in the Year of the Tiger |
Equity Research & Insights |
Lukas Strobl |
26/01/22 |
2021's Best and Worst Performing Funds |
Fund Research & Insights |
Sunniva Kolostyak |
07/01/22 |
China Equity Spotlight: JD vs Alibaba |
Equity Research & Insights |
Kate Lin |
29/11/21 |
China's Market Risks Are Nothing New |
ETF Investing Ideas & News |
Daniel Sotiroff |
18/11/21 |
Evergrande Remains in the Spotlight |
Bond Investing |
Kate Lin |
25/10/21 |
Chinese Stocks for the Policy Clampdown |
Equity Research & Insights |
Sunniva Kolostyak |
15/10/21 |
China's New Policy Drives Middle-Class Spending |
Video |
Kate Lin |
13/10/21 |
China Market Snapshot |
Equity Research & Insights |
Lewis Jackson |
07/10/21 |
China Opportunities After Evergrande |
Equity Research & Insights |
Vikram Barhat |
30/09/21 |
The Upside of China's Regulatory Squeeze |
Fund Research & Insights |
Holly Black |
28/09/21 |
The Evergrande Crisis Explained: Should Investors Worry? |
Equity Research & Insights |
Lewis Jackson |
21/09/21 |
China's Crackdown: Time to Sell? |
Fund Research & Insights |
James Gard |
16/08/21 |
Fresh Regulatory Worries for Tencent |
Equity Research & Insights |
|
06/08/21 |
What Next for China? |
Special Report |
James Gard |
26/07/21 |
3 Themes for China's Year of the Ox |
Equity Research & Insights |
James Gard |
11/02/21 |
How US Sanctions Affect China Investors |
ETF Research & Insights |
Holly Black |
28/01/21 |
3 China Stock Picks |
Investment Trust Research & Insights |
Holly Black |
25/01/21 |
A Year Since Lockdown: China in 5 Charts |
Economic Insights |
James Gard |
25/01/21 |
Key Trends for China Investors |
Investment Trust Research & Insights |
Holly Black |
20/01/21 |
China: Themes for 2021 and Beyond |
Economic Insights |
James Gard |
09/12/20 |
Ant Group IPO: What You Need to Know |
Equity Research & Insights |
Holly Black |
08/10/20 |
What the US Huawei Ban Means for Chip Makers |
Equity Research & Insights |
Holly Black |
28/09/20 |
Can Healthcare Stocks Keep Climbing? |
Equity Research & Insights |
Holly Black |
16/07/20 |
Is China's Recovery Already Underway? |
Economic Insights |
Holly Black |
29/06/20 |
Coronavirus: Investors Should Hold Their Nerve |
Economic Insights |
Carolyn Szaflik |
03/02/20 |